Immuno-genomic landscape of osteosarcoma

Wu CC1, Beird HC1, Andrew Livingston J2,3, Advani S3, Mitra A1, Cao S4, Reuben A5, Ingram D6, Wang WL6, Ju Z4, Hong Leung C7, Lin H7, Zheng Y1, Roszik J1, Wang W4, Patel S2, Benjamin RS2, Somaiah N2, Conley AP2, Mills GB8, Hwu P2, Gorlick R3, Lazar A6, Daw NC3, Lewis V9, Futreal PA10; 1 Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 2 Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 3 Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 4 Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 5 Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 6 Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 7 Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 8 Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 9 Department of Orthopedic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 10 Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. afutreal@mdanderson.org.